Hypoglycemic Effects of Fermented Red Ginseng in Subject With Impaired Fasting Glucose or Type 2 Diabetes

Chonbuk National University Hospital42 enrolled

Overview

This study was conducted to investigate the effects of daily supplementation of fermented red ginseng (FRG) on glycemic status in subjects with impaired fasting glucose (IFG) or type 2 diabetes.

This study was a 4 weeks, randomized, double-blind, placebo-controlled trial. Forty-two subjects with IFG or type 2 diabetes were randomly allocated to 2 groups to consume placebo or FRG three times per day for 4 weeks. Fasting and postprandial glucose profiles during meal tolerance test were assessed before and after the intervention.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

Conditions

Impaired Glucose or Type 2 Diabetes

Interventions

Fermented Red GinsengDIETARY_SUPPLEMENT

Fermented red ginseng 2.7g/day for 4 weeks

PlaceboDIETARY_SUPPLEMENT

Placebo 2.7g/day for 4 weeks

Eligibility

Sex: ALLMin age: 20 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 20-75 years with fasting glucose 100\~140 mg/dL at least two of the following Exclusion Criteria: * Lipid metabolic disorder * Acute or chronic inflammatory disease * Taking medication of corticosteroid within 4 weeks of the study * Cardiovascular disease (arrhythmia, heart failure, myocardial infarction or patient with pacemaker) * Allergic or hypersensitive to any of the ingredients in the test products * Participation in other clinical trials within 2 months * Abnormal hepatic liver function or renal disease (acute/chronic renal failure or nephrotic syndrome) * Taking medication of lipid phosphates within 3 months of the study etc,

Locations (1)

Clincial Trial Center for Functional Foods

Jeonju, Jeollabok-do, South Korea

Outcomes

Primary Outcomes

Glucose profiles during meal tolerance test

Fasting and postprandial glucose profiles during meal tolerance test were assessed before(baseline) and after the intervention

Time frame: 4 weeks

Secondary Outcomes

Change in lipid profiles

Change in lipid profiles were assessed before(baseline) and after the intervention

Time frame: 4 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.